Phosphite-borane compounds, and method of making and using the same
AssigneeBoron Biologicals, Inc.
InventorsBernard F. Spielvogel, Anup Sood
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoron Biologicals, Inc.
InventorsBernard F. Spielvogel, Anup Sood
Estimating the term…
Methods of making phosphite-borane compounds of the formula ##STR1## wherein: each R.sub.1 is independently selected from: H; C.sub.1 -C.sub.10 alkyl; alkylaryl; aralkyl; aryl; monovalent metal ions; nucleosides; and quaternary ammonium ions, (R.sub.4).sub.4 N.sup.+, in which the substituents R.sub.4 of the ammonium nitrogen atom are H or C.sub.1 -C.sub.10 alkyl; R.sub.2 is H or C.sub.1 -C.sub.10 alkyl; and R.sub.3 is CNCH.sub.2 CH.sub.3.sup.+ BF.sub.4.sup.-, COOH, carboxyl salts, COOR.sub.5, or CONHR.sub.5, wherein R.sub.5 is C.sub.1 -C.sub.10 alkyl, alkylaryl, aralkyl, or aryl; with the proviso that if at least one of the R.sub.1 substituents is H, nucleoside, monovalent metal ion, or quaternary ammonium ion, then R.sub.3 may also be CN, via synthetic routes comprising hydrolysis. The phosphorous-boron adducts of the invention are bioactive in character, variously exhibiting anti-tumor, anti-inflammatory, and hypolipidemic activity.
A process for the preparation of a dialkylphosphite-borane compound comprising hydrolyzing a trialkylphosphite-borane compound of the formula:
Dependencies are inferred from the claim text.